Accelerating adoption of innovative CV devices - thought provoking session at
@CVCTForum #CVCT2023
🫀 TAVR: one of the most disruptive medical technologies in recent years - yet the US was the 42nd country to approve in 2014. More to think about: “Regulation enables the innovation.”
🫀 If CardioMEMES was a drug, with the evidence that supports its use, would it have a grade 1 recommendation in guidelines?
⬇️ framework for device adoption is complex